Amanda Bäcker

Artiklar

Article: BMC PSYCHIATRY. 2022;22(1):625

The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study.

Brynte C; Aeschlimann M; Barta C; Begeman AHA; Bäcker A; Crunelle CL; Daigre C; De Fuentes-Merillas L; Demetrovics Z; Dom G; López LG; Icick R; Johnson B; Joostens P; Kapitány-Fövény M; Karsinti E; Kiefer F; Konstenius M; Levin FR; Luderer M; Markus W; Matthys F; Moggi F; Palma-Alvarez RF; Paraskevopoulou M; Ramos-Quiroga JA; Schellekens A; Soravia LM; Therribout N; Thomas A; van de Glind G; van Kernebeek MW; Vollstädt-Klein S; Vorspan F; van den Brink W; Franck J
Article: EUROPEAN ADDICTION RESEARCH. 2020;26(4-5):211-222

Onset and Severity of Early Disruptive Behavioral Disorders in Treatment-Seeking Substance Use Disorder Patients with and without Attention-Deficit/Hyperactivity Disorder.

González RA; Vélez-Pastrana MC; Blankers M; Bäcker A; Konstenius M; Holtmann M; Levin FR; Noack M; Kaye S; Demetrovics Z; van de Glind G; van den Brink W; Schellekens A; ICASA Group